Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA) (UNMASK)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01683721 |
|
Recruitment Status : Unknown
Verified September 2013 by ApniCure, Inc..
Recruitment status was: Recruiting
First Posted : September 12, 2012
Last Update Posted : September 4, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Obstructive Sleep Apnea |
| Study Type : | Observational |
| Estimated Enrollment : | 1000 participants |
| Observational Model: | Cohort |
| Time Perspective: | Prospective |
| Official Title: | The UNMASK Study: A Post-Market Longitudinal Observational Study of the WinxTM Sleep Therapy System for the Treatment of Obstructive Sleep Apnea (OSA) |
| Study Start Date : | September 2012 |
| Estimated Primary Completion Date : | December 2013 |
| Estimated Study Completion Date : | February 2014 |
| Group/Cohort |
|---|
| Winx |
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Exclusion Criteria
- Has a severe respiratory disorder, such as severe lung disease, pneumothorax, etc.
- Has loose teeth or advanced periodontal disease.
- Is under the age of 18.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01683721
| Contact: Lawrence Siegel, MD | 650-361-9399 | lsiegel@apnicure.com |
| United States, Florida | |
| St. Petersburg Sleep Disorders Center | Recruiting |
| St. Petersburg, Florida, United States, 33707 | |
| Contact 727-360-0853 | |
| Principal Investigator: Neil T Feldman, MD | |
| United States, Texas | |
| Sleep Medicine Associates of Texas (SMAT) | Recruiting |
| Dallas, Texas, United States, 75231 | |
| Contact: Philip Becker, MD 214-389-1740 | |
| Principal Investigator: Philip Becker, MD | |
| Responsible Party: | ApniCure, Inc. |
| ClinicalTrials.gov Identifier: | NCT01683721 |
| Other Study ID Numbers: |
12023 |
| First Posted: | September 12, 2012 Key Record Dates |
| Last Update Posted: | September 4, 2013 |
| Last Verified: | September 2013 |
|
Apnea Sleep Apnea Syndromes Sleep Apnea, Obstructive Respiration Disorders Respiratory Tract Diseases |
Signs and Symptoms, Respiratory Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders Nervous System Diseases |

